Skip to main content

Genenta Science S.p.A.

GNTA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001838716

No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.

Superinvestors holding GNTA, Q2 2026

See all superinvestors

No superinvestor reported holding GNTA in Q2 2026.